Clinical Trial Update: Nadolol for Proliferating Infantile Hemangiomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for nadolol in treating proliferating infantile hemangiomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Hemangioma

Drugs mentioned

• Nadolol (Nadolol)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Infantile Hemangioma | Phase 2 | Status: COMPLETED